Vor Biopharma VOR Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's change in lease liabilities?
- Vor Biopharma (VOR) reported change in lease liabilities of -$61K in Q1 2026.
- How has Vor Biopharma's change in lease liabilities changed year-over-year?
- Vor Biopharma's change in lease liabilities increased by 94.2% year-over-year, from -$1.05M to -$61K.
- What is the long-term trend for Vor Biopharma's change in lease liabilities?
- Over 4 years (2021 to 2025), Vor Biopharma's change in lease liabilities has grown at a -1.5% compound annual growth rate (CAGR), from -$2.56M to -$2.41M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.